219 related articles for article (PubMed ID: 34373963)
1. Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds.
Li Petri G; Raimondi MV; Spanò V; Holl R; Barraja P; Montalbano A
Top Curr Chem (Cham); 2021 Aug; 379(5):34. PubMed ID: 34373963
[TBL] [Abstract][Full Text] [Related]
2. Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review).
Bhat AA; Singh I; Tandon N; Tandon R
Eur J Med Chem; 2023 Jan; 246():114954. PubMed ID: 36481599
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective biotransformations of racemic and meso pyrrolidine-2,5-dicarboxamides and their application in organic synthesis.
Chen P; Gao M; Wang DX; Zhao L; Wang MX
J Org Chem; 2012 Apr; 77(8):4063-72. PubMed ID: 22463383
[TBL] [Abstract][Full Text] [Related]
4. Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffold.
Cheng XC; Wang Q; Fang H; Xu WF
Curr Med Chem; 2008; 15(4):374-85. PubMed ID: 18288992
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric synthesis of polyfunctionalized pyrrolidines from sulfinimine-derived pyrrolidine 2-phosphonates. Synthesis of pyrrolidine 225C.
Davis FA; Xu H; Wu Y; Zhang J
Org Lett; 2006 May; 8(11):2273-6. PubMed ID: 16706504
[TBL] [Abstract][Full Text] [Related]
6. Catalysis of 3-pyrrolidinecarboxylic acid and related pyrrolidine derivatives in enantioselective anti-Mannich-type reactions: importance of the 3-acid group on pyrrolidine for stereocontrol.
Zhang H; Mitsumori S; Utsumi N; Imai M; Garcia-Delgado N; Mifsud M; Albertshofer K; Cheong PH; Houk KN; Tanaka F; Barbas CF
J Am Chem Soc; 2008 Jan; 130(3):875-86. PubMed ID: 18163619
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library.
Tsou EL; Chen SY; Yang MH; Wang SC; Cheng TR; Cheng WC
Bioorg Med Chem; 2008 Dec; 16(24):10198-204. PubMed ID: 19008111
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach.
Tian X; Field TB; Switzer AG; Mazur AW; Ebetino FH; Wos JA; Berberich SM; Jayasinghe LR; Obringer CM; Dowty ME; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
J Med Chem; 2006 Jul; 49(15):4745-61. PubMed ID: 16854081
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective ring contraction of 2,5-diketopiperazines: An innovative approach to the synthesis of promising bioactive 5-membered scaffolds.
Coursindel T; Restouin A; Dewynter G; Martinez J; Collette Y; Parrot I
Bioorg Chem; 2010 Oct; 38(5):210-7. PubMed ID: 20609458
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in silico studies of some new pyrrolidine derivatives and their biological evaluation for analgesic and anti-inflammatory activity.
Mishra AK; Anjali K; Singh H; Mishra A; Kumar A
Ann Pharm Fr; 2023 Sep; 81(5):801-813. PubMed ID: 36931432
[TBL] [Abstract][Full Text] [Related]
11. A rational approach towards a new ferrocenyl pyrrolidine for stereoselective enamine catalysis.
Petruzziello D; Stenta M; Mazzanti A; Cozzi PG
Chemistry; 2013 Jun; 19(24):7696-700. PubMed ID: 23649888
[TBL] [Abstract][Full Text] [Related]
12. Efficient method for the synthesis of chiral pyrrolidine derivatives via ring-closing enyne metathesis reaction.
Yang Q; Alper H; Xiao WJ
Org Lett; 2007 Mar; 9(5):769-71. PubMed ID: 17279763
[TBL] [Abstract][Full Text] [Related]
13. Highly enantioselective construction of fused pyrrolidine systems that contain a quaternary stereocenter: concise formal synthesis of (+)-conessine.
Jiang B; Xu M
Angew Chem Int Ed Engl; 2004 May; 43(19):2543-6. PubMed ID: 15127448
[No Abstract] [Full Text] [Related]
14. Tandem construction of biological relevant aliphatic 5-membered N-heterocycles.
Łowicki D; Przybylski P
Eur J Med Chem; 2022 May; 235():114303. PubMed ID: 35344904
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric synthesis of cis-2,5-disubstituted pyrrolidine, the core scaffold of β3-AR agonists.
Xu F; Chung JY; Moore JC; Liu Z; Yoshikawa N; Hoerrner RS; Lee J; Royzen M; Cleator E; Gibson AG; Dunn R; Maloney KM; Alam M; Goodyear A; Lynch J; Yasuda N; Devine PN
Org Lett; 2013 Mar; 15(6):1342-5. PubMed ID: 23451898
[TBL] [Abstract][Full Text] [Related]
17. Enantiodivergent Synthesis of (+)- and (-)-Pyrrolidine 197B: Synthesis of trans-2,5-Disubstituted Pyrrolidines by Intramolecular Hydroamination.
Pérez SJ; Purino MA; Cruz DA; López-Soria JM; Carballo RM; Ramírez MA; Fernández I; Martín VS; Padrón JI
Chemistry; 2016 Oct; 22(43):15529-15535. PubMed ID: 27624405
[TBL] [Abstract][Full Text] [Related]
18. Cephalostatin analogues--synthesis and biological activity.
Flessner T; Jautelat R; Scholz U; Winterfeldt E
Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
[TBL] [Abstract][Full Text] [Related]
19. Hydroxylated pyrrolidines. Enantiospecific synthesis of all-cis 2,3,4,5-substituted pyrrolidine derivatives from serine.
Verma SK; Atanes MN; Busto JH; Thai DL; Rapoport H
J Org Chem; 2002 Feb; 67(4):1314-8. PubMed ID: 11846680
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 1-deoxysphingosine derivatives with conformationally restricted pyrrolidinediol head groups.
Dougherty AM; McDonald FE; Liotta DC; Moody SJ; Pallas DC; Pack CD; Merrill AH
Org Lett; 2006 Feb; 8(4):649-52. PubMed ID: 16468733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
